Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Saw this on the Yahoo board...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by NewToInvesting7on Apr 29, 2021 4:21pm
183 Views
Post# 33095501

RE:Saw this on the Yahoo board...

RE:Saw this on the Yahoo board...I saw that post too, but would take it with a grain of salt unless one of the parties actually mentions it publicly.  Probably should note that the same person said that Stage is one of two suppliers to Rexall, but without seeing the memo or a NR, not worth speculating over.

Cheers!


DeepSyd wrote:

"StageZero and Ichor will be providing PCR testing to Rexall for COVID diagnostic purposes.  Kits will run in the 200s for 1 and 300s for two.  Not sure if StageZero will make this public soon however it could be a significant boost in revenue!"

There's no link to the news, apparently it was in a Rexall internal memo. 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities